01 Sep 2014 --- Following the sales decline at the beginning of the year, Natraceutical stabilizes its turnover in the second quarter and protects its contribution margin. Natraceutical ended the first six months of the year with a turnover of 17.74 M€ compared to 18.51 M€ in June 2013, primarily driven by a 6.0% decline in sales in the first quarter after the change of purchase dynamics in the pharmaceutical channel.
